1、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549FORM 10-Q?QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIESEXCHANGE ACT OF 1934For the quarterly period ended September 30,2023or?TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIESEXCHANGE ACT OF 1934F
2、or the transition period fromtoCommission File Number:1-10864UnitedHealth Group Incorporated(Exact name of registrant as specified in its charter)Delaware(State or other jurisdiction ofincorporation or organization)41-1321939(I.R.S.EmployerIdentification No.)UnitedHealth Group Center9900 Bren Road E
3、astMinnetonka,Minnesota(Address of principal executive offices)55343(Zip Code)(952)936-1300(Registrants telephone number,including area code)Securities registered pursuant to Section 12(b)of the Act:Title of each classTrading Symbol(s)Name of each exchange on which registeredCommon Stock,$.01 par va
4、lueUNHNew York Stock ExchangeIndicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities ExchangeAct of 1934 during the preceding 12 months(or for such shorter period that the registrant was required to file such reports),and(2)h
5、as beensubject to such filing requirements for the past 90 days.Yes?No?Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant toRule 405 of Regulation S-T(232.405 of this chapter)during the preceding 12 months(or for s
6、uch shorter period that the registrant wasrequired to submit such files).Yes?No?Indicate by check mark whether the registrant is a large accelerated filer,an accelerated filer,a non-accelerated filer,a smaller reportingcompany,or an emerging growth company.See the definitions of“large accelerated fi